INHALE THERAPEUTIC SYSTEMS, INC.

Company

NEKTAR THERAPEUTICS

Filed

February 12, 2002

Accession Number

0000912938-02-000210

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →